Clinical Trial Update: Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients

View source ↗

Summary

A completed open-label, multicenter prospective trial assessing quality of life in patients with multiple sclerosis sponsored by Bayer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis | Status: COMPLETED